This protocol addresses sarcoidosis presenting with posterior uveitis or panuveitis — ocular involvement that typically requires systemic rather than local therapy alone.
For posterior uveitis or panuveitis in the setting of sarcoidosis, systemic therapy is usually indicated. Posterior segment involvement carries a greater risk to vision and generally cannot be managed by topical measures alone.
When adequate disease control requires more than low-dose corticosteroids, corticosteroid-sparing agents are added. The approach involves a cytotoxic agent alongside corticosteroids — the specific agent and regimen are selected based on the individual clinical picture.